Manfred Hensel

2.9k total citations
68 papers, 1.6k citations indexed

About

Manfred Hensel is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Manfred Hensel has authored 68 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 41 papers in Genetics and 29 papers in Oncology. Recurrent topics in Manfred Hensel's work include Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (40 papers) and Viral-associated cancers and disorders (18 papers). Manfred Hensel is often cited by papers focused on Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (40 papers) and Viral-associated cancers and disorders (18 papers). Manfred Hensel collaborates with scholars based in Germany, Austria and United States. Manfred Hensel's co-authors include Anthony D. Ho, Stephan Stilgenbauer, Michael Hallek, Dirk Winkler, Hartmut Döhner, Raymonde Busch, Andreas Bühler, Thorsten Zenz, Georg Hopfinger and Jennifer Edelmann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Manfred Hensel

66 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manfred Hensel Germany	21	988	903	517	490	310	68	1.6k
Bernard Lenormand France	20	638 0.6×	949 1.1×	336 0.6×	512 1.0×	355 1.1×	52	1.6k
Ilaria Del Giudice Italy	24	1.5k 1.5×	1.3k 1.4×	764 1.5×	408 0.8×	305 1.0×	82	1.9k
Timothy J. Murphy United States	9	778 0.8×	799 0.9×	399 0.8×	310 0.6×	158 0.5×	19	1.2k
Alessandra Pucciarini Italy	14	413 0.4×	691 0.8×	345 0.7×	413 0.8×	359 1.2×	19	1.4k
Robert Coupland Canada	22	477 0.5×	844 0.9×	241 0.5×	683 1.4×	329 1.1×	40	1.7k
Pierre Feugier France	18	782 0.8×	715 0.8×	413 0.8×	225 0.5×	217 0.7×	68	1.1k
K Owusu-Ankomah United Kingdom	14	1.3k 1.3×	1.1k 1.2×	761 1.5×	331 0.7×	194 0.6×	17	1.6k
Sarah F. Paternoster United States	16	707 0.7×	657 0.7×	605 1.2×	254 0.5×	387 1.2×	25	1.5k
Miguel Alcoceba Spain	21	460 0.5×	439 0.5×	312 0.6×	442 0.9×	362 1.2×	79	1.3k
Susan O’Brien United States	15	1.4k 1.4×	933 1.0×	536 1.0×	499 1.0×	997 3.2×	24	2.2k

Countries citing papers authored by Manfred Hensel

Since Specialization

Citations

This map shows the geographic impact of Manfred Hensel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Hensel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Hensel more than expected).

Fields of papers citing papers by Manfred Hensel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Hensel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Hensel. The network helps show where Manfred Hensel may publish in the future.

Co-authorship network of co-authors of Manfred Hensel

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Hensel. A scholar is included among the top collaborators of Manfred Hensel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Hensel. Manfred Hensel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kriegsmann, Katharina, Manfred Hensel, Eike C. Buss, et al.. (2019). Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent Prognosis. Clinical Lymphoma Myeloma & Leukemia. 19(10). e581–e587. 4 indexed citations

Welz, Tanya, Christoph Wyen, & Manfred Hensel. (2017). Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients. Oncology Research and Treatment. 40(3). 120–127. 9 indexed citations

Stangel, Martin, Ralf Gold, David Pittrow, et al.. (2016). Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry. Therapeutic Advances in Neurological Disorders. 9(3). 165–179. 13 indexed citations

Hentrich, Marcus, Christian Hoffmann, Franz Mosthaf, et al.. (2014). Therapy of HIV-associated lymphoma—recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG). Annals of Hematology. 93(6). 913–921. 18 indexed citations

Stangel, Martin, Ulrich Baumann, Michael Borte, et al.. (2012). Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry. Journal of Clinical Immunology. 33(S1). 67–71. 7 indexed citations

Witzens‐Harig, Mathias, Manfred Hensel, Michael Unterhalt, & Klaus Herfarth. (2011). Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial. BMC Cancer. 11(1). 87–87. 20 indexed citations

Kirch, Wilhelm, Ralf Gold, Manfred Hensel, et al.. (2010). Prospektive Versorgungsforschungsstudie zur Therapie mit Immunglobulinen (SIGNS). Medizinische Klinik. 105(9). 647–651. 6 indexed citations

Hensel, Manfred, et al.. (2008). Complementary and alternative medicine in patients with chronic lymphocytic leukemia. Supportive Care in Cancer. 17(1). 47–52. 18 indexed citations

Hensel, Manfred, Axel Benner, Kai Neben, et al.. (2007). High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B‐cell chronic lymphocytic leukemia. International Journal of Cancer. 121(5). 978–983. 13 indexed citations

10.

Ho, Anthony D. & Manfred Hensel. (2006). Pentostatin for the Treatment of Indolent Lymphoproliferative Disorders. Seminars in Hematology. 43(2 Suppl 2). S2–S10. 13 indexed citations

11.

Schmitt, Christina, et al.. (2006). One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?. Leukemia Research. 30(12). 1563–1568. 12 indexed citations

12.

Mey, Ulrich, Katjana Orlopp, Dimitri Flieger, et al.. (2006). Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma. Cancer Investigation. 24(6). 593–600. 42 indexed citations

13.

Schmitt, Christina, Brigitta Balogh, Albrecht Leo, et al.. (2005). The bcl-2/IgH rearrangement in a population of 204 healthy individuals: Occurrence, age and gender distribution, breakpoints, and detection method validity. Leukemia Research. 30(6). 745–750. 38 indexed citations

14.

Hensel, Manfred, Eike C. Buss, Markus Tiemann, et al.. (2004). Secondary follicular lymphoma of the bone, transformed into large cell lymphoma, in a patient with chronic lymphocytic leukaemia: an uncommon manifestation of Richter's syndrome. European Journal Of Haematology. 72(3). 217–221. 4 indexed citations

15.

Hensel, Manfred, Christoph Fiehn, & Anthony D. Ho. (2003). Stammzelltransplantation bei prim�ren systemischen Vaskulitiden. Medizinische Klinik. 98(1). 13–18. 1 indexed citations

16.

Hensel, Manfred & Anthony D. Ho. (2003). Successful treatment of a patient with hairy cell leukemia and pentostatin‐induced autoimmune thrombocytopenia with rituximab. American Journal of Hematology. 73(1). 37–40. 10 indexed citations

17.

Hensel, Manfred, et al.. (2003). Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia. British Journal of Haematology. 122(4). 600–606. 52 indexed citations

18.

Hensel, Manfred, Andreas Schneeweiß, Hans‐Peter Sinn, et al.. (2002). Stem Cell Dose and Tumorbiologic Parameters as Prognostic Markers for Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy with Autologous Blood Stem Cell Support. Stem Cells. 20(1). 32–40. 8 indexed citations

19.

Hensel, Manfred, Andreas Schneeweiß, Hans‐Peter Sinn, et al.. (2002). P53 is the strongest predictor of survival in high‐risk primary breast cancer patients undergoing high‐dose chemotherapy with autologous blood stem cell support. International Journal of Cancer. 100(3). 290–296. 29 indexed citations

20.

Egerer, Gerlinde, Manfred Hensel, & Anthony D. Ho. (2001). Infectious complications in chronic lymphoid malignancy. Current Treatment Options in Oncology. 2(3). 237–244. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact